The Center’s staff works very closely to create a well-integrated multidisciplinary team (Surgery, Oncology, Diagnostic Radiology, Radiotherapy, Nuclear Medicine, Pathology, Oncological Psychology, Plastic/Reconstructive Surgery).

The various experts discuss collegially all the cases. The diagnostic and therapeutic choices are always shared with the patients.

At San Raffaele there are approximately 9000 hospitalizations for tumors each year (approx. 17.2%), with 6000 tumor surgeries (approx. 30%)

Every week, a multi-specialty team meets to set up a diagnostic and therapeutic pathway for every patient.

 

All patients are handled according to two main areas:

  • Team dedicated to patients with onco-hematological diseases. The Oncology Hematology Units treats patients affected by lymphomas and cronic leukemias, by acute leukemias and myelomas. The Unit performs autologous and allogenic transplants.
  • Team dedicated to patients with epithelial and solid tumors. The Medical Oncology Unit treats all solid tumors in cooperation with the Radiotherapy Unit and the various Surgery Units.

The two areas cooperate for the implementation of procedures for autologous and allogenic transplants.

In this multidisciplinary context, the anatomic pathology and the laboratory analysis departments both cover a key role. These clinical areas cooperate with the research labs of the Department of Experimental Oncology where all the oncological researches are developed and performed.   

San Raffaele is a model of translational medicine, where lab findings are transformed into clinic applications (from bench to bed and from bed to bench). Some diseases can benefit from special fast tracks, which guarantee a minim interval between the first access to the hospital and the first treatment. In 15 days, the patient goes from the first visit to the actual therapy. A dedicated psychological support is available for all oncological patients.

 

  • Gastroenterological Surgery: Esophagus tumors, Stomach tumors, Small intestine tumors, Colon and rectum tumors, Tumors of anal canal (sentinel node)
  • Hematology: Blood cancers
  • Hepatobiliary Liver tumors
  • Gynecology: Female genital apparatus (benign and malignant tumors)
  • Breast Unit
  • Pancreas Unit: Adenocarcinoma, Cystic tumors, Endocrine tumors
  • Urology: Male uro-genital apparatus tumors
  • Ophthalmology: Conjunctival tumors, Eyes tumors, Intraocular tumors
  • Dermatology: Melanoma
  • Neurosurgery and Gamma Knife: Brain tumors (benign and malignant)
  • Endocrinology: Thyroid tumors, Parathyroid tumors, Adrenal gland tumors
  • Thoracic Surgery: Mediastinal tumors, Lung tumors, Trachea tumors, Diaphragm tumors, Pleural tumors
  • Otolaryngology: Nose tumors, Paranasal sinus tumors, Oral cavity tumors, Ear tumors, Salivary glands tumors
  • Orthopedics: Orthopedics tumors
  • Medical Oncology Medical Genetics

 

San Raffaele is also a point of reference for its use of advanced diagnostic and therapeutic technologies:

  • Nuclear medicine and PET Center:
    San Raffaele is one of the leading research and clinical application centers in Europe in the neurological, cardiac and oncological fields.
    San Raffaele has 2 cyclotrons for PET scans and 4 tomographs for Total Body PET/CT to study oncological, neurological and cardiac diseases.
  • Neuroradiology
  • Diagnostic radiology.

RADIOTHERAPY
Our Unit performs about 2000 external beam radiotherapy treatments per year. Every treatment follows international protocols and internal guidelines, to offer the best possible therapy to its patients. The Radiotherapy Unit offers the most innovative treatments: 3D-conformal radiotherapy, 3D-CRT; Intensity modulated radiotherapy, IMRT, Tomotherapy, RapidArc, Total Body Irradiation, TB.

TOMOTHERAPY
Our center was one of the first in Italy and in Europe to have this type of equipment. It allows to integrate CT systems for the control, and automatic repositioning of the patient by using a helical intensity-modulated radiotherapy. It guarantees a very high precision of its rays selectively irradiating the tumor while preserving healthy tissues.

At San Raffaele Hospital this type of treatment is frequently combined with a PET/CT (for a better accurate definition of the volumes of the treatment) and adequate techniques for the control of the patient’s positioning and organ breathing movements during the treatment of soft lesions. This combination becomes a unique system complying Tomotherapy and a metabolic guide. Compared to more conventional treatments (3D conformal radiotherapy and serial IMRT), where the usual amount provided is around 60-70 Gy in 30-35 fractions, this system, thanks to its helical modulated-intensity radiation (helical IMRT) allows to selectively irradiate the tumor preserving the healthy tissues, with higher doses in fewer fractions (1-15 fractions according to the type of treatment).

RAPIDARC – TOTAL BODY IRRADIATION
A sophisticated computerized system attached to a linear accelerator, which allows for a very precise and fast radiotherapy, by describing an arc around the patient in just 70 seconds. It provides intensity-modulated treatments (IMRT) irradiating very deep and small size lesions, in a very precise and accurate way in just two minutes. This volumetric technique increases the accuracy and precision of the treatment, thus its effectiveness, reducing toxicity and collateral effects. RapidArc offers an intensity-modulated radiotherapy treatment in single or multiple arcs. The rotation of the linear accelerator’s head around the patient delivers an IMRT guided by images (IGRT) up to eight-times faster vs conventional IMRT.

TOTAL BODY IRRADIATION, TBI
This type of radiation is usually used in combination with chemotherapy for patients with hematologic malignancies who require marrow transplants.

 

The Center’s staff works very closely to create a well-integrated multidisciplinary team (Surgery, Oncology, Diagnostic Radiology, Radiotherapy, Nuclear Medicine, Pathology, Oncological Psychology, Plastic/Reconstructive Surgery).

The various experts discuss collegially all the cases. The diagnostic and therapeutic choices are always shared with the patients.

At San Raffaele there are approximately 9000 hospitalizations for tumors each year (approx. 17.2%), with 6000 tumor surgeries (approx. 30%)

Every week, a multi-specialty team meets to set up a diagnostic and therapeutic pathway for every patient.

 

All patients are handled according to two main areas:

  • Team dedicated to patients with onco-hematological diseases. The Oncology Hematology Units treats patients affected by lymphomas and cronic leukemias, by acute leukemias and myelomas. The Unit performs autologous and allogenic transplants.
  • Team dedicated to patients with epithelial and solid tumors. The Medical Oncology Unit treats all solid tumors in cooperation with the Radiotherapy Unit and the various Surgery Units.

The two areas cooperate for the implementation of procedures for autologous and allogenic transplants.

In this multidisciplinary context, the anatomic pathology and the laboratory analysis departments both cover a key role. These clinical areas cooperate with the research labs of the Department of Experimental Oncology where all the oncological researches are developed and performed.   

San Raffaele is a model of translational medicine, where lab findings are transformed into clinic applications (from bench to bed and from bed to bench). Some diseases can benefit from special fast tracks, which guarantee a minim interval between the first access to the hospital and the first treatment. In 15 days, the patient goes from the first visit to the actual therapy. A dedicated psychological support is available for all oncological patients.

 

  • Gastroenterological Surgery: Esophagus tumors, Stomach tumors, Small intestine tumors, Colon and rectum tumors, Tumors of anal canal (sentinel node)
  • Hematology: Blood cancers
  • Hepatobiliary Liver tumors
  • Gynecology: Female genital apparatus (benign and malignant tumors)
  • Breast Unit
  • Pancreas Unit: Adenocarcinoma, Cystic tumors, Endocrine tumors
  • Urology: Male uro-genital apparatus tumors
  • Ophthalmology: Conjunctival tumors, Eyes tumors, Intraocular tumors
  • Dermatology: Melanoma
  • Neurosurgery and Gamma Knife: Brain tumors (benign and malignant)
  • Endocrinology: Thyroid tumors, Parathyroid tumors, Adrenal gland tumors
  • Thoracic Surgery: Mediastinal tumors, Lung tumors, Trachea tumors, Diaphragm tumors, Pleural tumors
  • Otolaryngology: Nose tumors, Paranasal sinus tumors, Oral cavity tumors, Ear tumors, Salivary glands tumors
  • Orthopedics: Orthopedics tumors
  • Medical Oncology Medical Genetics

 

San Raffaele is also a point of reference for its use of advanced diagnostic and therapeutic technologies:

  • Nuclear medicine and PET Center:
    San Raffaele is one of the leading research and clinical application centers in Europe in the neurological, cardiac and oncological fields.
    San Raffaele has 2 cyclotrons for PET scans and 4 tomographs for Total Body PET/CT to study oncological, neurological and cardiac diseases.
  • Neuroradiology
  • Diagnostic radiology.

RADIOTHERAPY
Our Unit performs about 2000 external beam radiotherapy treatments per year. Every treatment follows international protocols and internal guidelines, to offer the best possible therapy to its patients. The Radiotherapy Unit offers the most innovative treatments: 3D-conformal radiotherapy, 3D-CRT; Intensity modulated radiotherapy, IMRT, Tomotherapy, RapidArc, Total Body Irradiation, TB.

TOMOTHERAPY
Our center was one of the first in Italy and in Europe to have this type of equipment. It allows to integrate CT systems for the control, and automatic repositioning of the patient by using a helical intensity-modulated radiotherapy. It guarantees a very high precision of its rays selectively irradiating the tumor while preserving healthy tissues.

At San Raffaele Hospital this type of treatment is frequently combined with a PET/CT (for a better accurate definition of the volumes of the treatment) and adequate techniques for the control of the patient’s positioning and organ breathing movements during the treatment of soft lesions. This combination becomes a unique system complying Tomotherapy and a metabolic guide. Compared to more conventional treatments (3D conformal radiotherapy and serial IMRT), where the usual amount provided is around 60-70 Gy in 30-35 fractions, this system, thanks to its helical modulated-intensity radiation (helical IMRT) allows to selectively irradiate the tumor preserving the healthy tissues, with higher doses in fewer fractions (1-15 fractions according to the type of treatment).

RAPIDARC – TOTAL BODY IRRADIATION
A sophisticated computerized system attached to a linear accelerator, which allows for a very precise and fast radiotherapy, by describing an arc around the patient in just 70 seconds. It provides intensity-modulated treatments (IMRT) irradiating very deep and small size lesions, in a very precise and accurate way in just two minutes. This volumetric technique increases the accuracy and precision of the treatment, thus its effectiveness, reducing toxicity and collateral effects. RapidArc offers an intensity-modulated radiotherapy treatment in single or multiple arcs. The rotation of the linear accelerator’s head around the patient delivers an IMRT guided by images (IGRT) up to eight-times faster vs conventional IMRT.

TOTAL BODY IRRADIATION, TBI
This type of radiation is usually used in combination with chemotherapy for patients with hematologic malignancies who require marrow transplants.